Michael Jensen

Michael Jensen is a seasoned Chief Financial Officer with extensive experience in the healthcare and biotechnology sectors. Current responsibilities at StimLabs as CFO began in February 2024, following a tenure at Synlogic, Inc. from March 2022 to December 2023. Previous roles include CFO positions at Intrinsic Therapeutics, Inc., Taconic Biosciences, and Injured Workers Pharmacy, where leadership in finance, accounting, and operational strategies were critical to company growth. Michael also contributed significantly to Straumann North America and Siemens Healthcare, overseeing financial planning and analysis for major divisions with substantial sales. Educational credentials include a Master's in Finance and Accounting from Copenhagen Business School, an MBA exchange program at Duke University, and a Bachelor's degree in Finance and International Business from Towson University.